Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation-Reference-Cited by-同舟云学术

Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation

Published:2018-02 Issue:2 Volume:7 Page:167-175
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Devine Emily Beth¹,Perfetto Eleanor²³,Pickard A Simon⁴,Schumock Glen T⁴,Segal Jodi B⁵,Cannon Eileen⁶,Gagnon Jean Paul⁷,Brixner Diana I⁸,Garrison Louis P¹,Murray Michael D⁹

Affiliation:

1. The Comparative Health Outcomes Policy & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA

2. Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA

3. National Health Council, Washington, DC 20036-4561, USA

4. Department of Pharmacy Systems, Outcomes & Policy, University of Illinois at Chicago, Chicago, IL 60612, USA

5. Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

6. Pharmaceutical Research & Manufacturers Association of America Foundation, Washington, DC 20004, USA

7. School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA

8. Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT 84112, USA

9. Purdue University College of Pharmacy & Regenstrief Institute, Indianapolis, IN 46202, USA

Abstract

The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term ‘patient-centered outcomes research’ (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2017-0059

Reference25 articles.

1. Medicare prescription drug, improvement, and modernization Act of 2003 (2003), 108–173. Public Law.

2. H.R. 1. American Recovery and Reinvestment Act, of 2009 (2009), 111–115. Public Law.

3. H.R. 3590. Patient Protection and Affordable Care Act (2010), 111–148. Public Law.

4. Comparative-Effectiveness Research — Implications of the Federal Coordinating Council's Report

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers;Journal of Comparative Effectiveness Research;2018-02